Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) EPS (Basic) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 18.46%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -123.64%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 10.04%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 55.65%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 28.85%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 24.41%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -112.00%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -5.04%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn 93.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 93.26%
Dec 31, 2025 -700.00%
Sep 30, 2025 72.73%
Jun 30, 2025 28.57%
Mar 31, 2025 -10,281.82%
Dec 31, 2024 125.00%
Sep 30, 2024 -266.67%
Jun 30, 2024 -250.00%
Mar 31, 2024 -1,200.00%
Dec 31, 2023 0.00%
Sep 30, 2023 62.50%
Jun 30, 2023 -133.33%
Mar 31, 2023 105.88%
Dec 31, 2022 -300.00%
Sep 30, 2022 98.11%
Jun 30, 2022 700.00%
Mar 31, 2022 -750.00%
Dec 31, 2021 300.00%
Sep 30, 2021 -13,995.48%
Jun 30, 2021 75.00%
Mar 31, 2021 83.33%
Dec 31, 2020 -150.00%
Sep 30, 2020 57.14%
Jun 30, 2020 -300.00%
Mar 31, 2020 -100.00%
Dec 31, 2019 -77.78%
Sep 30, 2019 -600.00%
Jun 30, 2019 75.00%
Mar 31, 2019 62.50%
Dec 31, 2018 200.00%
Sep 30, 2018 50.00%
Jun 30, 2018 -100.00%
Mar 31, 2018 -433.33%
Dec 31, 2017 175.00%
Sep 30, 2017 60.00%
Jun 30, 2017 0.00%
Mar 31, 2017 -50.00%
Dec 31, 2016 92.16%
Sep 30, 2016 -150.00%
Jun 30, 2016 -300.00%
Mar 31, 2016 50.00%
Sep 30, 2015 -200.00%
Jun 30, 2015 -66.67%
Mar 31, 2015 -300.00%
Sep 30, 2014 166.67%
Jun 30, 2014 400.00%
Mar 31, 2014 171.32%
Dec 31, 2013 -150.00%
Sep 30, 2013 -200.00%
Jun 30, 2013 -120.00%
Mar 31, 2013 -170.10%
Dec 31, 2012 33.33%
Sep 30, 2012 -1,115.55%
Jun 30, 2012 0.00%
Mar 31, 2012 -33.33%
Dec 31, 2011 -62.50%
Sep 30, 2011 -99.78%
Jun 30, 2011 -16.67%